Health Archive » July, 2007

Health - July, 2007

188 articles

• Medical Device Maker Admits Guilt In FDA Case
• Baxter Recalls Infusion Pumps
• FDA, Officials Hit With Suit Over Cancer Drug
• Scientists Lobby EU For New Stem Cell Rules
• Citing Tellabs, Circuit Court Hands Baxter Victory
• J&J Settles Duragesic Suit For $2.5M
• Biomet Distributor, Exec Hit With Competition Suit
• Liability Claims Against Dexatrim Maker Dismissed
• States Fight Mediation In Drug Pricing Suit
• Denial Of Cert. Reversed In Blue Shield Class Action
• Dispute Over Drugs Hinders WTO Protocol
• Avandia Survives Scrutiny From FDA Panel
• Court OKs $36M Legal Bill In Bristol-Myers Suit
• CMS Creates Uncertainty With Proposed Changes
• China To Get Tough On Product Safety
• UnitedHealth CEO's Options Freeze Extended
• AstraZeneca Chips Away At Seroquel Case
• Caremark Repels Whistleblower Charges
• Nigeria Delays Suit Over Pfizer Clinical Trials
• Judge Says Abbott Can't Add Products To Suit
• Judge Extends Stay In Antitrust OxyContin Suit
• Novartis's Zelnorm Enters Restricted Access Program
• Aventis Triumphs In Patent Suit Over ALS Drug
• In Landmark Case, Federal Circuit Finds For Merck
• Serenex Sues Ex-Employee For Alleged Espionage
• Judge Pushes New Vioxx Cases Forward
• Court Vacates Infringement Order Against Cordis
• Medtronic To Acquire Rival, Settle Spinal Patent Suit
• Stay Approved In Bone-Fusing Staple Patent Dispute
• Calif. Fines Kaiser Permanente $3M
• Ranbaxy, Glaxo Bury Hatchet Over Valtrex
• Suit Claims Theft Of Medical Software Trade Secrets
• Bavarian Nordic, Acambis Settle Smallpox Fight
• Judge Tentatively Dismisses Ditropan Complaint
• Judge Orders Mediation In Drug Pricing Suit
• Boston Scientific Jumps Into Medtronic's Patent Case
• Nanotechnology Stays Off Label: FDA Report
• Cardinal Health Settles With SEC For $35 Million
• Master Rejects Bextra Plaintiffs' Discovery Request
• Judge Allows Pharmanet Derivative Suit To Continue
• Patent Group Moves From Greenberg Traurig To Dreier
• Maximus Settles Medicaid Claim Probe
• Propulsid Suits Dismissed As Case Draws To A Close
• Glaxo Sales Drop As FDA Hearings Approach
• Roche, Bayer Present New Evidence Against Abbott
• Spanish Court Upholds Lipitor Patent
• Sanofi Mounts Offensive For Eloxatin
• States Bury Hatchet With TAP Over Drug Pricing
• Schering Sues Barr Over Brain Tumor Drug
• Jewish Mother Wins Discrimination Suit Against VA
• Zyprexa Plaintiff Wants To Go It Alone Against Eli Lilly
• Mayer Brown Balks At Bankruptcy Advisor's Suit
• Bausch & Lomb, CIBA Sued Over Contact Lens Patent
• Federal Circuit Affirms Invalidity Of Toprol Patents
• Medical Records Co. Hit With FLSA Suit
• Judge Tosses Some Accutane IBD Cases
• Mayne Renews Crusade For Colon Cancer Drug
• Federal Circuit Nixes Nucleonics' Patent Dispute
• Plaintiffs Accuse Novartis Of Violating Court Order
• Ephedra Still Causing Headaches For Diet Pill Makers
• Ortho-McNeil Sues Apotex Over Ultracet Patent
• Court Throws Out Gen-Probe's HPV License Suit
• Experts Rebutted In Pfizer's Celebrex Case
• Drug Exec, Son Sentenced To Jail For Insider Trading
• Pfizer Faces Class Action Over Employee Data Leak
• Wilson Sonsini Hit With Suit Over Missing Certificates
• Abbott Gets Third-Party Subpoenas Quashed
• Nigeria To File New Version Of Lawsuit Against Pfizer
• Appeals Court Keeps Merck Derivative Suit Alive
• Purdue Wins Appeal In OxyContin Liability Suit
• Court Revives Health Sciences Cos. Merger Dispute
• Assistant AG Joins Fulbright's Healthcare Practice
• Medtronic, Attys. Drain Defibrillator Plaintiff Pool
• Par, Ortho-McNeil Settle Ultracet Patent Spat
• House Bill Would Stifle FDA's Plan To Close Labs
• Bristol-Myers Pays $13M To Settle Pricing Class Action
• EU Consumer Chief To Stress Product Safety In China
• Drug Makers Seek Dismissal Of Wholesale Price Suit
• Abbott Aims To Quash Bayer Subpoena
• Abbott Bids To Toss New Government Claims
• Aredia Product-Liability Plaintiffs Amend Complaints
• Impax Appeals Prilosec Case To Federal Circuit
• Who's Liable When Data Is Improperly Disclosed?
• Cypress Returns Fire Against Glaxo Over Zantac
• Roche, Bayer Press Abbott To Turn Over Patent Deal
• Ex-King Pharmaceutical Employee Loses Bid For Fees
• Technicians Hit CVS With FLSA Suit
• Novo Nordisk Takes On Sanofi Over Insulin Pens
• YouTube Helps Solicit Participants For Paxil Payback
• Learned Intermediary Doctrine: Required By Law?
• Judge OKs Dismissal Of Some Ephedra Claims
• World Bank Bars Indian Drug Firms For Price-Fixing
• Novartis Chastised For Litigation Delay
• Abbott, Andrx Settle Biaxin XL Litigation
• DOJ Gets Behind Whistleblower Suit Against Fresenius
• Special Master OKs $70M Glaxo Settlement
• Sepracor, Barr Clash Over Asthma Drug
• Court Reopens Teva, Novartis Spat Over Herpes Drug
• Cipro Antitrust Case Goes To State Court
• Ephedra Judge Limits Doctor's Expert Testimony
• Appeals Court Revives HP Whistleblower Suit
• Alza, Ortho-McNeil Bid To Toss Ditropan Claims
• $3B Tyco Settlement Gets Preliminary Approval
• Taro Shareholders Defend Securities Fraud Complaint
• EMEA Issues Guidance On Biosimilar Drugs
• Boston Scientific Pays $195M To Bury Defibrillator MDL
• Beth Israel Arbitration Spat Spills Over To Court
• Clinical Integration And The Antitrust Rule Of Reason
• Xyrem Settlement Gets Green Light
• Viagra Case Focuses On Evidence Of Causation
• Zyprexa Suits Weigh Heavily On Eli Lilly's Future
• Boston Scientific Fights To Fire Subsidiary's Execs
• Walgreens Pays $20M To Settle With EEOC
• As Court Battle Rages, Pfizer's Celebrex Sales Soar
• Medtronic May Have To Rethink Defense
• First NCFE Exec Pleads Guilty To Securities Fraud
• Roche Expects IBD Suits' Dismissal In Accutane MDL
• Apotex Wins Appelate Reversal In Ofloxacin Case
• N.Y. Slams Drug Makers' Calls To Toss AWP Case
• Medtronic Hit With Catheter Patent Suit
• Plaintiffs Point To "Tellabs" In Pfizer Securities Suit
• Conflict Escalates Between Pharma, Bank
• Boehringer Sues Barr Over Generic Stroke Drug
• Judge Allows Aredia Plaintiffs To Alter Complaint
• House Gives Go Ahead To Drug Bill, Hurdles Remain
• Home Care Co. Invokes Top Court Ruling In FLSA Suit
• National Century VIPs Indicted For Investment Fraud
• Boston Scientific Seeks To Intervene In Medtronic Case
• Appeals Court Clears J&J In Remicade Suit
• Celebrex, Bextra Claims Withstand Judge's Scrutiny
• Accutane Plaintiffs Win Bid To Shield Docs
• Mylan ANDA Sparks Another Effexor Suit
• Pfizer Gains Victory In Irish Lipitor Case
• BioMedical Enterprises Seeks Suit Stay
• SEC Looks Into Dendreon Following FDA Disclosure
• AstraZeneca, Bristol-Myers Oppose "Do Over"
• Plaintiffs' Expert Testimony Struck From Baycol Case
• Plaintiff Attempts To Send Guidant Case To State Court
• Purdue Pharma Denies KV's Antitrust Allegations
• Merck Punches Back In Fosamax Case
• As Defibrillator Trial Approaches, Guidant Falters
• QLT Faces $70M Bill From Visudyne Ruling
• Pozen Settles Securities Class Action
• Ephedra Plaintiff Fights Herbalife's Bid To Bar Info
• Catheter Maker Claims Rivals Spread False Rumors
• Abbott Fails In Effort To End Pregnancy Test Case
• PharmaStem Blood Storage Patents Not Valid: Judge
• HIPAA Security Rule Update
• Patient Asks Judge To Rethink Crestor Ruling
• Judge Nixes Settlement Master In Seroquel Suit
• Nellson, Creditors Move To End Examination
• Asbestos Victims Attack Pfizer Over Bankruptcy Plan
• Seroquel Plaintiffs Agree To Dismiss 14 Of Their Own
• Ex-Cardinal Health Execs Settle Derivative Suits
• Defining Noncompete Provisions In Tennessee
• Wholesale Price Plaintiffs Call Damages Incomplete
• Plaintiffs Call For Guidant To Turn Over Device Data
• PwC To Pay $225M To Get Rid Of Tyco Case
• Judge Hands Pfizer A Mixed Bag In Celebrex Case
• Patent Co. Wants Subpoena Nixed
• SonoSite Claims GE Infringed Ultrasound Patents
• Pfizer Sued Over Hormone Replacement Drugs
• Herbalife Seeks To Bar Ephedra Data
• Prempro Judge OKs Case-Specific Discovery
• Requirements For Physician Noncompetes
• AstraZeneca Faces Call For Sanctions
• Judge Approves Ramp Corp. Settlement
• FDA Toughens Dietary Supplements Guidelines
• FDA Pens Deal With EU Over Food Safety
• No Zyprexa Negotiator In Seroquel Case: AstraZeneca
• SSRIs, Suicide Link Takes Center Stage In Forest Suits
• Label Doesn't Clear Merck From Vioxx Liability: Judge
• Nurses Attack Hospitals, DOJ Over Alleged Cartel
• Home Care Workers' Overtime Battle Takes New Tack
• Study Could Weaken Merck's Vioxx Defense: Report
• Lilly Suffers Setback In Zyprexa Suit
• ICU Medical Smacked With $4.75M Fee
• Court Deals Blow To Mylan In Norvasc Dispute
• Judge Greenlights Becton Dickinson Antitrust Suit
• CVS, Ex-Execs Settle Earnings Misstatement Claims
• FCPA: High Risks For The Medical Device Industry
• Another Blow To Medical Staff Peer Review Privilege
• Drug Makers Settle Suit Over Epilepsy Treatment
• Guidant Fights Plaintiffs' Bid For Sanctions
• Wyeth Fights Plaintiffs' Bid For Prempro Docs
• EC Calls For Nestle To Divest In Novartis Union
• Rite Aid Moves to Block Arbitration With Union
• Judge Sides With J&J in Defective Sutures Suit